Cite
HARVARD Citation
Siemers, E. et al. (2016). Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. Alzheimer's & dementia. 12 (2), pp. 110-120. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Siemers, E. et al. (2016). Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. Alzheimer's & dementia. 12 (2), pp. 110-120. [Online].